Drug Tissue Binding
Drug Tissue Binding is a pharmacokinetic process in which a drug reversibly associates with components of bodily tissues, distinguishing it from plasma protein binding by involving extracellular matrix, cellular structures, or specific tissue-resident molecules that sequester the drug outside the vascular compartment.
220
Publications
9.7K
Citations
732
Authors
238
Institutions
Publications per year
2017–2026
27
Parents
220
Arterial Paclitaxel Distribution and Deposition
Christopher J. Creel, Mark A. Lovich, Elazer R. Edelman · Circulation Research · 2000 · 275 citations
Rick D. Davis, David H. Peters, Donna McTavish · Drugs · 1994 · 238 citations
1–5 of 220
732
4
h-index
University at Buffalo, State University of New York, United States
4 publications · 84 citations
4
h-index
4
h-index
4
h-index
4
h-index
1–5 of 732
238
University at Buffalo, State University of New York
Buffalo, United States
8 h-index
19 publications
843 citations
AstraZeneca (Sweden)
Södertälje, Sweden
5 h-index
12 publications
1.2K citations

University of Minnesota
Minneapolis, United States
5 h-index
11 publications
823 citations
Pfizer (United States)
New York, United States
4 h-index
12 publications
1.2K citations

Uppsala University
Uppsala, Sweden
4 h-index
14 publications
446 citations
University of Washington
Seattle, United States
4 h-index
7 publications
412 citations
University of Wisconsin–Madison
Madison, United States
3 h-index
7 publications
138 citations

University of Manchester
Manchester, United Kingdom
3 h-index
3 publications
57 citations
1–8 of 238
Repository · 19 publications · 715 citations
14
h-index
15 publications · 469 citations
12
h-index
11 publications · 422 citations
10
h-index
9 publications · 333 citations
9
h-index
7 publications · 559 citations
7
h-index
1–5